1-propanol has been researched along with Dyslipidemias in 9 studies
1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This controlled, randomized clinical trial was designed to compare the efficacy and safety of fenofibrate, policosanol and a combination of these 2 in lowering low-density-lipoprotein cholesterol (LDL-C) in elderly patients with mixed dyslipidemia." | 9.27 | Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study. ( Chen, SY; Fang, NY; Jiang, H; Jiao, QP; Lu, J; Sheng, J; Wang, HY; Zheng, SB, 2018) |
| " This controlled, randomized clinical trial was designed to compare the efficacy and safety of fenofibrate, policosanol and a combination of these 2 in lowering low-density-lipoprotein cholesterol (LDL-C) in elderly patients with mixed dyslipidemia." | 5.27 | Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study. ( Chen, SY; Fang, NY; Jiang, H; Jiao, QP; Lu, J; Sheng, J; Wang, HY; Zheng, SB, 2018) |
| "Berberine (BERB) and a combination (COMB) of berberine (CAS 2086-83-1) with policosanol (CAS 557-61-9), red yeast extract (containing monacolin, CAS 557-61-9), folic acid and astaxanthin were orally administered daily for 4 weeks to 40 subjects with moderate dyslipidemias divided in two parallel groups each of 20 subjects." | 5.12 | Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. ( Cicero, AF; Rovati, LC; Setnikar, I, 2007) |
| "This study aimed to systematically investigate whether sugarcane policosanol was effective and safe on dyslipidemia." | 2.58 | Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. ( Chen, G; Dong, H; Fang, K; Gong, J; Hu, M; Huang, Z; Jiang, S; Li, J; Lu, F; Qin, X; Wang, D; Yuan, F; Zhao, Y, 2018) |
| "Dyslipidemia is a major independent and reversible risk factor for these diseases: it is estimated that a reduction of 1 mmol/l (38 mg/dl) of LDL cholesterol is associated with a risk of developing a cardiovascular complication reduced by 25%, a reduction potentially achieved by life-style improvement associated to adequate dietary supplementation with bioactive substances." | 2.53 | Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data. ( Cicero, AF; Colletti, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C | 1 |
| Ding, Y | 1 |
| Si, Q | 1 |
| Li, K | 1 |
| Xu, K | 1 |
| Gong, J | 1 |
| Qin, X | 1 |
| Yuan, F | 1 |
| Hu, M | 1 |
| Chen, G | 1 |
| Fang, K | 1 |
| Wang, D | 1 |
| Jiang, S | 1 |
| Li, J | 1 |
| Zhao, Y | 1 |
| Huang, Z | 1 |
| Dong, H | 1 |
| Lu, F | 1 |
| Marchitto, N | 1 |
| Sindona, F | 1 |
| Fabrizio, A | 1 |
| Mauti, M | 1 |
| Andreozzi, S | 1 |
| Dalmaso, S | 1 |
| Raimondi, G | 1 |
| Elseweidy, MM | 1 |
| Mohamed, HE | 1 |
| Elrashidy, RA | 1 |
| Atteia, HH | 1 |
| Elnagar, GM | 1 |
| Wang, HY | 1 |
| Jiao, QP | 1 |
| Chen, SY | 1 |
| Sheng, J | 1 |
| Jiang, H | 1 |
| Lu, J | 1 |
| Zheng, SB | 1 |
| Fang, NY | 1 |
| Landi, F | 1 |
| Martone, AM | 1 |
| Salini, S | 1 |
| Zazzara, B | 1 |
| Calvani, R | 1 |
| Marzetti, E | 1 |
| Nesci, A | 1 |
| Di Giorgio, A | 1 |
| Giupponi, B | 1 |
| Santoro, L | 1 |
| Santoliquido, A | 1 |
| Askarpour, M | 1 |
| Ghaedi, E | 1 |
| Roshanravan, N | 1 |
| Hadi, A | 1 |
| Mohammadi, H | 1 |
| Symonds, ME | 1 |
| Miraghajani, M | 1 |
| Cicero, AF | 2 |
| Colletti, A | 1 |
| Rovati, LC | 1 |
| Setnikar, I | 1 |
3 reviews available for 1-propanol and Dyslipidemias
| Article | Year |
|---|---|
Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Fatty Alco | 2018 |
Policosanol supplementation significantly improves blood pressure among adults: A systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Blood Pressure; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; Randomized Contro | 2019 |
Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
Topics: Berberine; Biological Products; Cholesterol; Clinical Trials as Topic; Dietary Supplements; Drug The | 2016 |
4 trials available for 1-propanol and Dyslipidemias
| Article | Year |
|---|---|
Multiple functions of policosanol in elderly patients with dyslipidemia.
Topics: Aged; Carotid Intima-Media Thickness; Dyslipidemias; Fatty Alcohols; Humans; Platelet Aggregation | 2020 |
Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study.
Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Dyslipidemias; Fatty Alcohols; Female; Fenofibrate; H | 2018 |
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial.
Topics: Adult; Aged; Biological Products; Chromium; Citrus; Dietary Supplements; Dyslipidemias; Endothelial | 2019 |
Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.
Topics: Anticholesteremic Agents; Berberine; Cholesterol; Dietary Supplements; Drug Combinations; Dyslipidem | 2007 |
2 other studies available for 1-propanol and Dyslipidemias
| Article | Year |
|---|---|
Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
Topics: Berberine; Biological Products; Cassia; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; | 2018 |
Inhibition of Aortic Calcification by Policosanol in Dyslipidemic Rabbits Is Enhanced by Pentoxifylline: Potential Role of PCSK9.
Topics: Alkaline Phosphatase; Animals; Anticholesteremic Agents; Aorta; Aortic Diseases; Biomarkers; Bone Mo | 2018 |